AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

NIH’s Dr. Dieffenbach Shares Final Update from AIDS 2016

Carl Anne Day 3 FB Live - resized

In his third and final update from the International AIDS Conference (AIDS 2016) in Durban, South Africa, NIH’s Dr. Carl Dieffenbach discussed highlights of ongoing HIV cure research presented at the conference. Dr. Dieffenbach, the Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), spoke with his colleague…

HIV Vaccine Research: Update from NIH’s Dr. Dieffenbach from 2nd Day of AIDS 2016

Carl day 2 FB Live resized

As the second day of the International AIDS Conference (AIDS 2016) came to a close in Durban, South Africa, we caught up with Dr. Carl Dieffenbach again via Facebook Live to get his thoughts on some of the day’s highlights. He is Director of the Division of AIDS at NIH’s National Institute of Allergy and…

Dr. Fauci and Dr. Wolitski Discuss Highlights of AIDS 2016

Fauci Facebook live interview - resized

During the second day of sessions at the International AIDS Conference (AIDS 2016) in Durban, South Africa, AIDS.gov did a Facebook Live session with Dr. Tony Fauci of NIH and Dr. Rich Wolitski of HHS at the U.S. government exhibit booth. Dr. Fauci is the Director of the National Institute of Allergy and Infectious Diseases…

HIV Therapy for Breastfeeding Mothers Can Virtually Eliminate Transmission to Babies

Logo for National Institute of Allergy and Infectious Disease

HIV Therapy for Breastfeeding Mothers Can Virtually Eliminate Transmission to Babies For HIV-infected mothers whose immune system is in good health, taking a three-drug antiretroviral regimen during breastfeeding essentially eliminates HIV transmission by breast milk to their infants, according to results from a large clinical trial conducted in sub-Saharan Africa and India. These findings from…

Vaginal Ring May Cut HIV Infection Risk if Used Consistently

Vaginal ring - cropped July 2016

NIH Clinical Trial Will Clarify Relationship between Ring Adherence, HIV Infection Risk A new exploratory analysis of data from the ASPIRE study has found that using a drug-infused vaginal ring most or all of the time reduced the risk of HIV infection in women by at least 56 percent. This finding is being reported today…

NIH Expands Investment in HIV Cure Research

Logo for National Institute of Allergy and Infectious Disease

Six Research Teams to Lead Collaborative Investigations Worldwide The National Institutes of Health has awarded approximately $30 million in annual funding over the next five years to six research collaborations working to advance basic medical science toward an HIV cure. The awards comprise the second iteration of the Martin Delaney Collaboratory: Towards an HIV-1 Cure…

FDA approves Epclusa for treatment of chronic Hepatitis C virus infection

FDA logo - cropped - May 2016

First regimen to treat all six major HCV genotypes The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients with moderate to severe cirrhosis (decompensated cirrhosis), Epclusa is approved for use in combination with the drug ribavirin….

LGBT Health: Celebrating Our Progress and Looking Ahead

HHS Pride blog image - cropped HER size - June 2016

Summary: Here at HHS, our support for LGBT health and wellbeing has spanned across the department. If there is a single thread which ties together the incredible work done by each member of the Health and Human Services family, it is the belief that every American deserves the same opportunity to live a healthy, happy…